These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 19962156
1. Invasive pneumococcal infections among vaccinated children in the United States. Park SY, Van Beneden CA, Pilishvili T, Martin M, Facklam RR, Whitney CG, Active Bacterial Core surveillance team. J Pediatr; 2010 Mar; 156(3):478-483.e2. PubMed ID: 19962156 [Abstract] [Full Text] [Related]
2. Herd immunity and pneumococcal conjugate vaccine: a quantitative model. Haber M, Barskey A, Baughman W, Barker L, Whitney CG, Shaw KM, Orenstein W, Stephens DS. Vaccine; 2007 Jul 20; 25(29):5390-8. PubMed ID: 17583392 [Abstract] [Full Text] [Related]
3. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, Jackson D, Thomas A, Beall B, Lynfield R, Reingold A, Farley MM, Whitney CG. J Infect Dis; 2007 Nov 01; 196(9):1346-54. PubMed ID: 17922399 [Abstract] [Full Text] [Related]
4. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine. Black S, France EK, Isaacman D, Bracken L, Lewis E, Hansen J, Fireman B, Austrian R, Graepel J, Gray S, Klein NP. Pediatr Infect Dis J; 2007 Sep 01; 26(9):771-7. PubMed ID: 17721369 [Abstract] [Full Text] [Related]
5. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine. Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, Parkinson AJ, Santosham M, Craig MJ, O'Brien KL. Clin Infect Dis; 2008 Aug 15; 47(4):476-84. PubMed ID: 18627249 [Abstract] [Full Text] [Related]
6. Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. McEllistrem MC, Adams JM, Patel K, Mendelsohn AB, Kaplan SL, Bradley JS, Schutze GE, Kim KS, Mason EO, Wald ER. Clin Infect Dis; 2005 Jun 15; 40(12):1738-44. PubMed ID: 15909260 [Abstract] [Full Text] [Related]
7. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2008 Feb 15; 57(6):144-8. PubMed ID: 18272956 [Abstract] [Full Text] [Related]
8. Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study. Kellner JD, Vanderkooi OG, MacDonald J, Church DL, Tyrrell GJ, Scheifele DW. Clin Infect Dis; 2009 Jul 15; 49(2):205-12. PubMed ID: 19508165 [Abstract] [Full Text] [Related]
16. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae. Dagan R. Clin Microbiol Infect; 2009 Apr 15; 15 Suppl 3():16-20. PubMed ID: 19366365 [Abstract] [Full Text] [Related]
17. Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine. Aguiar SI, Serrano I, Pinto FR, Melo-Cristino J, Ramirez M, Portuguese Surveillance Group for the Study of Respiratory Pathogens. Clin Microbiol Infect; 2008 Sep 15; 14(9):835-43. PubMed ID: 18844684 [Abstract] [Full Text] [Related]